204 related articles for article (PubMed ID: 27699535)
1. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
Vermorken JB
Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
[TBL] [Abstract][Full Text] [Related]
2. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
3. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
Vermorken JB; Psyrri A; Mesía R; Peyrade F; Beier F; de Blas B; Celik I; Licitra L
Ann Oncol; 2014 Apr; 25(4):801-807. PubMed ID: 24577117
[TBL] [Abstract][Full Text] [Related]
5. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
Psyrri A; Rampias T; Vermorken JB
Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
[TBL] [Abstract][Full Text] [Related]
6. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
[TBL] [Abstract][Full Text] [Related]
7. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
Rieke DT; Keilholz U
Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
[TBL] [Abstract][Full Text] [Related]
8. HPV-positive head and neck tumours, a distinct clinical entity.
Nevens D; Nuyts S
B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
10. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC.
Hess J
Recent Results Cancer Res; 2017; 206():233-242. PubMed ID: 27699543
[TBL] [Abstract][Full Text] [Related]
11. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
[TBL] [Abstract][Full Text] [Related]
13. The New Face of Head and Neck Cancer: The HPV Epidemic.
Lewis A; Kang R; Levine A; Maghami E
Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
[TBL] [Abstract][Full Text] [Related]
14. HPV-Related Head and Neck Squamous Cell Carcinomas.
Marszałek A; Szylberg Ł
Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531
[TBL] [Abstract][Full Text] [Related]
15. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use.
Murthy V; Swain M; Teni T; Pawar S; Kalkar P; Patil A; Chande A; Ghonge S; Laskar SG; Gupta T; Budrukkar A; Agrawal J
Indian J Cancer; 2016; 53(3):387-393. PubMed ID: 28244466
[TBL] [Abstract][Full Text] [Related]
17. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
18. The role of cytology in the era of HPV-related head and neck carcinoma.
Roy-Chowdhuri S; Krishnamurthy S
Semin Diagn Pathol; 2015 Jul; 32(4):250-7. PubMed ID: 25638437
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]